Lipopolysaccharide/interferon-γ and not transforming growth factor β inhibits retinal microglial migration from retinal explant

British Journal of Ophthalmology

Volumn 87, Issue 4, 2003, Pages 481-487

  Carter, D A ^a   Dick, Andrew D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOSTIMULATION; INFLAMMATION; MICROGLIA; NERVE DEGENERATION; PHENOTYPE; PRIORITY JOURNAL; RETINA; RETINA BLOOD VESSEL; SIGNAL TRANSDUCTION;

ANTIGENS, CD45; CELL ADHESION; CELL MOVEMENT; CULTURE TECHNIQUES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MICROGLIA; PHENOTYPE; RETINA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037383762     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.4.481     Document Type: Article

References (61)

1. Streilein JW, Takeuchi M, Taylor AW. Immune privilege, T cell tolerance and tissue-restricted autoimmunity. Hum Immunol 1997;52:138-43.
2. Wenkel H, Chen PW, Ksander BR, et al. Immune privilege is extended, then with drawn, from allogeneic tumor cell grafts placedin the sub-retinal space. Invest Ophthalmol Vis Sci 1999;40:3202-8.
3. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curt Opin Immunol 2001;13:114-9.
4. Welge-Lussen U, Wilsch C, Neuhardt T, et al. Loss of anterior chamber-associated immune deviation (ACAID) in aged retinal degeneration (rd) mice. Invest Ophthalmol Vis Sci 1999;40:3209-14.
5. Butler TL, McMenamin PG. Resident and infiltrating immune cells in the uveal tract in early EAU. Invest Ophthalmol Vis Sci 1996;37:2195-210.
6. Forrester JV, McMenamin PG, Holthouse I, et al. Localisation and characterisation of major histocompatibility complex class II-positive cells in the posterior segment of the eye:implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1994;35:64-77.
7. Dick AD. Retinal antigen-specific T cells mediated experimental autoimmune uveoretinitis in PVG. Ocular Immunol Inflamm 1995;3:261-70.
8. Prendergrast RA, Illiff CE, Coskuncan NM, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1998;39:754-62.
9. Jiang HR, Lumsden L, Forrester JV. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci 1999;40:3177-85.
10. low parenchymal microglia. Br J Ophthalmol 1995;79:834-40.
11. Zhang J, Wu GS, Ishimoto S, et al. Expression of major histocompatibility complex molecules in rodent retina:immunohistochemical study. Invest Ophthalmol Vis Sci 1997;38:148-57.
12. Provis JM, Penfold PL, Edwards AJ, et al. Human retinal microglial expression of immune markers and relationship to the glial limitans. Glia 1995;14:243-56.
13. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001;36:118-24.
14. Ford AL, Foulcher E, Lemckert FA, et al. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 1996;184:1737-45.
15. Frade JM, Barde YA. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 1998;20:35-41.
16. Egensperger R, Maslim J, Bisti S, et al. Fate of DNA from retinal cells dying during development and uptake by microglia and macroglia. Brain Res 1996;97:1-8.
17. Barton KD, Dentinger MP, Krohel G, et al. Qualitative and quantitative ultrastructural observations on retinal ganglion cell layer of rat after intraorbital optic nerve crush. J Neurocytol 1986;15:345-62.
18. Humphrey MF, Moore SR. Microglial responses to focal lesions of the rabbit retina:correlation with neural and macroglial reactions. Glia 1996;16:325-41.
19. Roque RS, Imperial CJ, Caldwell RB. Microglial cells invade the outer retina as photoreceptors degenerate in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 1996;37:196-203.
20. Batchelor PE, Liberatore GT, Wong JY, et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell inederived neurotrophic factor. J Neurosci 1999;19:1708-16.
21. Wyss-Coray T, Lin C, Yan F et al. TGF-β promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat Med 2001;7:612-8.
22. Fischer H-G, Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 2001;166:2717-26.
23. Sedgewick JD, Schwender S, lmrich H, et al. Isolation and direct characterisation of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci 1991;88:7438-42.
24. Giulian D. Microglia and the immune pathology of Alzheimer disease. Am J Hum Genet 1999;65:13-18.
25. Constantinescu CS, Goodman DBP, Hilliard B, et al. Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products. Neurosci Lett 2000;287:171-4.
26. Broderick C, Duncan L, Taylor N, et al. IFN-γ and LPS-mediated IL-10-dependent suppression of retinal microglia activation. Invest Ophthalmol Vis Sci 2000;41:2613-22.
27. Aloisl F. Immune function of microglia. Glia 2001;36:165-79.
28. Hara Y, Caspi RR, Wiggert B, et al. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber associated immune deviation with interphotoreceptor retinoid-binding protein. J Immunol 1992;148:1685-92.
29. Takeuchi M, Alard P, Streilein JW. TGF-β promotes immune deviation by altering accessory signals of antigen presenting cells. J Immunol 1998;160:1589-97.
30. D'Orazio TJ, Niederkorn JY. A novel role for TGF-β and IL-10 in the induction of immune privilege. J Immunol 1998;160:2089-98.
31. Takahashi M, Ishimaru N, Yanagi K, et al. Requirement for spleen CD4+T cells in the immune privilege of the anterior chamber of the eye. Clin Exp Immunol 1999;116:231-7.
32. Ohta K, Yamagami S, Taylor AW, et al. IL-6 antagonizes TGF-β and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 2000;41:2591-9.
33. Cottrez F, Groux H, Regulation of TGF-β response during T cell activation is modulated by IL-10. J immunol 2001;167:773-8.
34. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000;292:1768.
35. Dick AD, Broderick C, Forrester JV, et al. Distribution of OX2 antigen and OX2 receptor within retina. Invest Ophthalmol Vis Sci 2001;42:170-6.
36. Smith S, Cartwright M. Spatial visualisation of apoptosis using a wholemount in situ DNA end-labeling technique. Biotechniques 1997;22:832-4.
37. Erwig LP, Kluth DC, Walsh GM, et al. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J Immunol 1998;161:1983-8.
38. Mertsch K, Hanisch UK, Kettenmann H, et al. Characterization of microglial cells and their response to stimulation in an organotypic retinal culture system. J Comp Neurol 2001;431:217-27.
39. Streilein JW, Cousins SW, Aqueous humor factors and their effect on the immune response in the anterior chamber. Curr Eye Res 1990;9:175-82.
40. Streilein JW, Wilbanks GA, Taylor A, et al. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review. Curt Eye Res 1992;11:41-7.
41. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 1993;685:713-39.
42. Eriksson NP, Persson JK, Svensson M, et al. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Exp Brain Res 1993;96:19-27.
43. Chan A, Magnus T, Gold R. Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines:mechanism for removal of apoptotic cells in the inflamed nervous system. Glia 2001;33:87-95.
44. Thanos S. Sick photoreceptors attract activated microglia from the ganglion cell layer: a model to study the inflammatory cascades in rats with inherited retinal dystrophy, Brain Res 1992;588:21-8.
45. Yuan L, Neufeld AH, Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 2001;64:523-32.
46. Chao CC, Hu S, Molitor TW, et al. Activated microgtia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992;149:2736-41.
47. Robertson MJ, Erwig LP, Liversidge J, et al. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis. Invest Ophthalmol Vis Sci 2002;43:(in press).
48. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages, J Immunol 1991;147:3815-22.
49. Bogdan C, Vodovotz Y, Nathan C, Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
50. Rizzo LV, Xu H, Chan CC, et al. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 1998;10:807-14.
51. el-Shabrawi Y, Livir-Rallatos C, Christen W, et al. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis. Ophthalmology 1998;105:1659-63.
52. Williams K, Dooley N, Ulvestad E, et al. IL-10 production by adult human derived microglial cells. Neurochem Int 1996;29:55-64.
53. Badie B, Schartner J, Vorpahl J, et al. Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro. Exp Neurol 2000;162:290-6.
54. Pazmany T, Kosa JP, Tomasi TB, et al. Effect of transforming growth factor-beta1 on microglial MHC-class II expression. J Neuroimmunol 2000;103:122-30.
55. Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Proc Natl Acad Sci USA 1993;90:3024-7.
56. Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995;374:647-50.
57. Kvanta A, Expression and secretion of transforming growth factor-beta in transformed and non-transformed retinal pigment epithelial cells. Ophthalmic Res 1994;26:361-7.
58. Fuss IJ, Boirivant M, Lacy Bet al. The interrelated roles of TGF-α and IL-10 in the regulation of experimental colitis. J Immunol 2002;168:900-8.
59. Camussi G, Turello E, Bussolino F, et al. Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int Arch Allergy Appl Immunol 1991;96:84-91.
60. Wang B, Zhuang L, Fujisawa H, et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999;162:277-83.
61. Magnus T, Chan A, Grauer O, et al. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol 2001;167:5004-10.